两种髂动脉分支装置维持髂内动脉血流的中期效果比较
该回顾性研究比较了E-liac与Zenith髂动脉分支装置(IBD)在累及髂动脉分叉动脉瘤中保留髂内动脉的中期结局。2014年至2018年共84例患者分别置入E-liac(n=44)或ZBIS(n=40),两组技术成功率、通畅率及再干预率无显著差异。
要点
- E-liac与ZBIS IBD的技术成功率均高(总体95.9%),组间无统计学差异。
- 中期免于再干预率与免于闭塞率两组相近,再干预率低。
- 两种装置在保留髂内动脉血流方面表现相当。
核心结论
- E-liac与ZBIS两种IBD在技术成功率、中期通畅率及低再干预率方面表现相当。
主要发现
- 总体技术成功率为95.9%(99例置入中95例成功),E-liac组93.7% vs ZBIS组98.0%(p=0.114)。
- 术后30天内ZBIS组发生3例闭塞,E-liac组1例;ZBIS组有1例围手术期死亡。
- 中位随访时间ZBIS组37个月,E-liac组28个月(p=0.657)。
- Kaplan-Meier估计免于再干预率ZBIS组87.2%(95%CI 82.6%~90.2%),E-liac组86.0%(95%CI 83.7%~89.1%)(p=0.563)。
- 免于闭塞率ZBIS组89.7%(95%CI 85.8%~94.5%),E-liac组95.3%(95%CI 92%~98.7%)(p=0.317)。
临床怎么用
- 对于累及髂动脉分叉的动脉瘤,E-liac与ZBIS均可作为保留髂内动脉的可行选择,中期效果相当。
局限性
- 本研究为回顾性分析,样本量有限,随访时间两组存在差异,且部分患者失访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose: To compare and contrast the midterm outcomes of the E-liac and Zenith (ZBIS) iliac branch devices (IBDs) for the preservation of the internal iliac artery (IIA) in aneurysms involving the iliac bifurcation. Materials and Methods: Between January 2014 and December 2018, 84 consecutive patients (median age 74 years; 76 men) were electively treated with the E-liac (n=44) or ZBIS (n=40) IBDs and were retrospectively analyzed to evaluate the technical success, patency, need for reintervention, and mortality associated with these devices. Results: Technical success was achieved in 95 of 99 implantations (95.9%) without any statistically significant difference between the groups (93.7% vs 98.0%, p=0.114). During the first 30 days, 3 occlusions in the ZBIS group and 1 in the E-liac group were identified. There was 1 perioperative death in the ZBIS group. The median follow-up was 37 months for the ZBIS group and 28 months for the E-liac group (p=0.657). Six patients from the ZBIS group and 7 from the E-liac group were lost to follow-up. Among the remaining, there were 2 further deaths recorded, 1 in each group. Four further reinterventions in the E-liac group and 2 in the ZBIS group were performed during follow-up. The Kaplan-Meier estimates of freedom from reintervention were 87.2% (95% CI 82.6% to 90.2%) for the ZBIS group and at 86.0% (95% CI 83.7% to 89.1%) for the E-liac group (p=0.563); the freedom from occlusion estimates were 89.7% (95% CI 85.8% to 94.5%) and 95.3% (95% CI 92% to 98.7%; p=0.317), respectively. Conclusion: The E-liac and the ZBIS IBDs showed equally high technical success, midterm patency, and low reintervention rates.
引用
- Mylonas SN, Ioannides G, Ahmad W, et al. Comparison of Two Iliac Branch Devices and Their Midterm Performance in Maintaining Blood Flow to the Internal Iliac Artery. J Endovasc Ther. 2020. PMID: 32580623. doi:10.1177/1526602820934762
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。